| P2093 | author name string | Giulio Cabrini | |
| | Maria Cristina Dechecchi | |
| | Anna Tamanini | |
| | Alessandra Santangelo | |
| P2860 | cites work | Characterization of extracellular circulating microRNA | Q24603537 |
| | Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | Q24614672 |
| | Current State of Circulating MicroRNAs as Cancer Biomarkers | Q26796328 |
| | Issues and prospects of microRNA-based biomarkers in blood and other body fluids | Q26991755 |
| | Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs | Q28119049 |
| | Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 |
| | Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas | Q31154294 |
| | Temozolomide: a milestone in neuro-oncology and beyond? | Q33372340 |
| | Identification of microRNAs associated with glioma diagnosis and prognosis | Q33688677 |
| | Pre-profiling factors influencing serum microRNA levels | Q33936328 |
| | MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development | Q35036059 |
| | Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma | Q35275041 |
| | MicroRNA (miRNA) in cancer | Q35583538 |
| | Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma | Q35788900 |
| | A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas | Q36091092 |
| | Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma | Q36560956 |
| | Epidemiology and molecular pathology of glioma | Q36577353 |
| | miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma | Q36608190 |
| | Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients. | Q36665167 |
| | The biology and function of exosomes in cancer | Q36737945 |
| | Versatile roles of extracellular vesicles in cancer | Q36737955 |
| | A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool | Q37641229 |
| | Emerging technologies in extracellular vesicle-based molecular diagnostics | Q38191663 |
| | Circulating microRNA biomarkers for glioma and predicting response to therapy. | Q38201683 |
| | Towards a molecular understanding of microRNA-mediated gene silencing | Q38528410 |
| | Circulating biomarkers for gliomas | Q38586617 |
| | MicroRNA as potential biomarkers in Glioblastoma | Q38590626 |
| | The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 |
| | Emerging role of microRNA-21 in cancer | Q38971467 |
| | microRNAs as cancer therapeutics: A step closer to clinical application | Q39244582 |
| | A specific miRNA signature in the peripheral blood of glioblastoma patients | Q45256953 |
| | Plasma MicroRNA-21 concentration may be a useful biomarker in glioblastoma patients | Q48409555 |
| | Identification of microRNAs as novel biomarkers for glioma detection: a meta-analysis based on 11 articles | Q48411865 |
| | Identification and Evaluation of Serum MicroRNA-29 Family for Glioma Screening | Q48466686 |
| | Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab | Q48956083 |
| | Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma. | Q53624071 |
| P433 | issue | 13 | |
| P921 | main subject | microRNA | Q310899 |
| | biomarker | Q864574 |
| P304 | page(s) | 277 | |
| P577 | publication date | 2017-07-01 | |
| P1433 | published in | Annals of Translational Medicine | Q26842362 |
| P1476 | title | Circulating microRNAs as emerging non-invasive biomarkers for gliomas | |
| P478 | volume | 5 | |